
December 14, 2022
Bathurst Metals Corp. (TSX-V:BMV) (OTC:BMVVD) (“Bathurst” or the “Company”) is pleased to announce the terms of a non-brokeredprivate placement (the “Flow-Through Offering”) whereby the Company plans to raise approximately CDN $200,000.00 through the issuance of 1,600,000 units with a subscription price of CDN $0.125 per unit (“Unit”). Each Unit consists of one flow-through common share (“Share”) and one Share purchase warrant to purchase one additional non flow-through Share (“Warrant Share”) exercisable at a price of CDN $0.25 per Warrant Share for a period of two years from the date of issue of the Units.
The Flow-Through Offering is expected to close on or before December 31, 2022.
The Company intends to use the gross proceeds from the flow-through portion of the Flow-Through Offering to incur Canadian Exploration Expenses that are Flow-Through Mining Expenditures (as such terms are defined in the Income Tax Act (Canada)). The Company will renounce such Canadian Exploration Expenses with an effective date of no later than December 31, 2022.
The proceeds from the Flow-Through Shares issued under the Flow-Through Offering will be used in part to fund the Company’s 2023 exploration and evaluation program on the Peerless Project.
The Company also announces a non-brokered private placement financing of up to 400,000 units (the “Units”) of securities at a price of CDN $0.10 per Unit for aggregate gross proceeds of up to CDN $40,000.00 (the “Non Flow-Through Offering”). Each Unit will be comprised of one Share and one non-transferable Share purchase warrant, with each whole warrant entitling the holder to purchase one additional Share at a price of CDN $0.20 for one year. The net proceeds will be used to pay agent’s commissions and administrative expenses. The Non Flow-Through Offering is expected to close no later than December 31, 2022.
Both private placements are subject to the approval of the TSX Venture Exchange. All Shares issued will be subject to a four month and one day hold period which will expire on the date that is four months and one day from the date of issue.
On behalf of the Board of Directors
Bathurst Metals Corp.
For more information contact Harold Forzley, Chief Executive Officer
Neither TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
BMV:CA
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.
The Conversation (0)
01 February 2022
Bathurst Metals
Exploring Undervalued Assets in Nunavut
Exploring Undervalued Assets in Nunavut Keep Reading...
7h
Brien Lundin: Gold, Bonds Sending Warning — Here's What's Next
Brien Lundin, editor of Gold Newsletter, shares his latest thoughts on gold, saying that for the last couple of months the price has largely been rising alongside real yields in the bond market. In his view, that's a potentially concerning sign for what's ahead. Click here to sign up for the New... Keep Reading...
08 September
John Kaiser: Gold's New Price Base, Plus Stocks I'm Watching Now
John Kaiser of Kaiser Research believes the "mother of all resource junior bull cycles" is currently in its fourth inning, with a "wall of cash" headed for the sector. In his view, now is the time for investors to research which stocks they want to buy.Don't forget to follow us @INN_Resource for... Keep Reading...
08 September
Peruvian Metals on Track for Full Production for 2026 at the Aguila Norte Processing Plant and Reports Positive Sample Results from the Tailings Area
Peruvian Metals Corp. (TSXV: PER,OTC:DUVNF) (OTC PINK: DUVNF) ("Peruvian Metals" or the "Company") announces the completion of a major overall and maintenance program and the year-to-date production results for 2026 at its 80-per-cent-owned Aguila Norte processing plant ("Aguila Norte" or the... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00






